POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $18,387 | -42.9% | 10,447 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $32,177 | -41.9% | 10,447 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $55,369 | -90.9% | 10,447 | -81.2% | 0.00% | -90.9% |
| Q4 2020 | $611,000 | +4.1% | 55,691 | -15.8% | 0.01% | -38.9% |
| Q3 2020 | $587,000 | – | 66,136 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $10,454,000 | 1.67% |
| Boxer Capital, LLC | 1,251,055 | $12,536,000 | 0.44% |
| Pentwater Capital Management LP | 4,967,227 | $49,772,000 | 0.41% |
| KNOTT DAVID M | 29,566 | $296,000 | 0.10% |
| Perceptive Advisors | 1,575,490 | $15,786,000 | 0.10% |
| Virtus ETF Advisers LLC | 24,287 | $243,000 | 0.10% |
| Advisory Services Network, LLC | 256,772 | $2,573,000 | 0.08% |
| J. Goldman & Co LP | 202,501 | $2,029,000 | 0.08% |
| Ikarian Capital, LLC | 85,837 | $861,000 | 0.07% |
| Regent Investment Management LLC | 25,000 | $251,000 | 0.06% |